| RS122454124 |
RPS6KA3
|
Health Risk |
Pathogenic |
Coffin-Lowry syndrome, Coffin-Lowry syndrome |
| RS122454125 |
RPS6KA3
|
Health Risk |
Pathogenic |
Coffin-Lowry syndrome, Coffin-Lowry syndrome |
| RS122454126 |
RPS6KA3
|
Health Risk |
Pathogenic |
Coffin-Lowry syndrome, Thyroid cancer |
| RS122454127 |
RPS6KA3
|
Health Risk |
Likely pathogenic |
Coffin-Lowry syndrome, Coffin-Lowry syndrome |
| RS122454128 |
RPS6KA3
|
Health Risk |
Pathogenic |
Coffin-Lowry syndrome, Coffin-Lowry syndrome |
| RS122454129 |
RPS6KA3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 19 |
| RS122454130 |
RPS6KA3
|
Health Risk |
Pathogenic |
Coffin-Lowry syndrome, Coffin-Lowry syndrome |
| RS122454131 |
RPS6KA3
|
Health Risk |
Pathogenic |
Coffin-Lowry syndrome, Coffin-Lowry syndrome |
| RS1224542443 |
RAG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS122455132 |
SLC16A2
|
Health Risk |
Pathogenic |
Allan-Herndon-Dudley syndrome, Intellectual disability |
| RS1224554825 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS122456133 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness 2A |
| RS122456134 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness |
| RS122456135 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness |
| RS122456136 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness, type 2A |
| RS1224562361 |
PEX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS122457137 |
DCX
|
Health Risk |
Pathogenic/Likely pathogenic |
Lissencephaly type 1 due to doublecortin gene mutation, Subcortical laminar heterotopia |
| RS122458138 |
ACSL4
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 63 |
| RS122458139 |
ACSL4
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 63 |
| RS122458140 |
FHL1
|
Health Risk |
Pathogenic |
X-linked scapuloperoneal muscular dystrophy, X-linked myopathy with postural muscle atrophy |
| RS122458141 |
FHL1
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS122458142 |
FHL1
|
Health Risk |
Pathogenic |
Myopathy, reducing body |
| RS122458143 |
FHL1
|
Health Risk |
Pathogenic |
Myopathy, reducing body |
| RS122458144 |
FHL1
|
Health Risk |
Pathogenic |
Myopathy, reducing body |
| RS122458145 |
FHL1
|
Health Risk |
Likely pathogenic |
Myopathy, reducing body |
| RS122459146 |
FHL1
|
Health Risk |
Pathogenic |
Myopathy, reducing body |
| RS122459147 |
FHL1
|
Health Risk |
Pathogenic |
Myopathy, reducing body |
| RS122459148 |
FHL1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 6, Emery-Dreifuss muscular dystrophy 6 |
| RS122459149 |
FHL1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 6, X-linked myopathy with postural muscle atrophy |
| RS1224597817 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome, Arrhythmogenic right ventricular dysplasia 2 |
| RS1224600457 |
SRD5A2
|
Health Risk |
Pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS122460150 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Orofaciodigital syndrome I |
| RS122460152 |
ARSL
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked chondrodysplasia punctata 1, X-linked chondrodysplasia punctata 1 |
| RS122460153 |
ARSL
|
Health Risk |
Likely pathogenic |
X-linked chondrodysplasia punctata 1, X-linked chondrodysplasia punctata 1 |
| RS122460154 |
ARSL
|
Health Risk |
Pathogenic |
X-linked chondrodysplasia punctata 1, X-linked chondrodysplasia punctata 1 |
| RS122460155 |
ARSL
|
Health Risk |
Pathogenic |
X-linked chondrodysplasia punctata 1, X-linked chondrodysplasia punctata 1 |
| RS122460156 |
TRAPPC2
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia tarda, Spondyloepiphyseal dysplasia tarda |
| RS122460157 |
CDKL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Atypical Rett syndrome, Developmental and epileptic encephalopathy |
| RS122460158 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS122460159 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1224602711 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS122461160 |
IL1RAPL1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 21 |
| RS122461161 |
IL1RAPL1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 21 |
| RS122461162 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Christianson syndrome |
| RS122461163 |
HSD17B10
|
Health Risk |
Pathogenic |
HSD10 mitochondrial disease, HSD10 mitochondrial disease |
| RS1224612016 |
TFR2
|
Health Risk |
Likely pathogenic |
Hemochromatosis type 3, Hemochromatosis type 3 |
| RS122462164 |
HSD17B10
|
Health Risk |
Pathogenic |
HSD10 mitochondrial disease, HSD10 mitochondrial disease |
| RS122462165 |
ZIC3
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS122462166 |
ZIC3
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS12246234 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1F, Usher syndrome type 1F |
| RS1224625808 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS122463167 |
ZIC3
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS122463168 |
ZIC3
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS1224632697 |
MEGF8
|
Health Risk |
Likely pathogenic |
Carpenter syndrome, Carpenter syndrome |
| RS1224639550 |
PLCB4
|
Health Risk |
Likely pathogenic |
— |
| RS1224640834 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia |
| RS1224647778 |
COL17A1
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1A, Amelogenesis imperfecta type 1A |
| RS122467169 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS122467170 |
FOXP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS122467171 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS122467172 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS122467173 |
FOXP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS122467174 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS122467175 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS122468176 |
MBTPS2
|
Health Risk |
Pathogenic |
IFAP syndrome 1, with or without BRESHECK syndrome |
| RS122468177 |
MBTPS2
|
Health Risk |
Pathogenic |
IFAP syndrome 1, with or without BRESHECK syndrome |
| RS122468178 |
MBTPS2
|
Health Risk |
Pathogenic |
IFAP syndrome 1, with or without BRESHECK syndrome |
| RS122468179 |
MBTPS2
|
Health Risk |
Pathogenic |
IFAP syndrome 1, with or without BRESHECK syndrome |
| RS122468180 |
MBTPS2
|
Health Risk |
Pathogenic |
IFAP syndrome 1, with or without BRESHECK syndrome |
| RS122468181 |
UPF3B
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 14, Syndromic X-linked intellectual disability 14 |
| RS122468182 |
UPF3B
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability 14, Syndromic X-linked intellectual disability 14 |
| RS1224689084 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1224691808 |
TET2
|
Health Risk |
Pathogenic |
— |
| RS1224695466 |
SCO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex IV deficiency, nuclear type 4 |
| RS1224729035 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS1224731205 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1224736770 |
GDF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated microphthalmia 4, Microphthalmia |
| RS1224744059 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1224745720 |
EYS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1224762841 |
ZFYVE26
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS1224775480 |
PIGN
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Inborn genetic diseases |
| RS1224777335 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS1224783275 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1224786667 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS1224814897 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS1224819887 |
MYO7A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS1224820591 |
BRAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1224834751 |
MAN1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rafiq syndrome, Rafiq syndrome |
| RS1224841813 |
EFEMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, autosomal recessive |
| RS1224850132 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS1224857205 |
RFXAP
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS1224862076 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS1224874674 |
SPINT2
|
Health Risk |
Likely pathogenic |
Congenital secretory sodium diarrhea 3, Congenital secretory sodium diarrhea 3 |
| RS1224883896 |
ATM
|
Health Risk |
Pathogenic |
Breast carcinoma, Ataxia-telangiectasia syndrome |
| RS1224922793 |
IRF6
|
Health Risk |
Pathogenic |
Orofacial cleft 6, susceptibility to |
| RS1224934895 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS1224946467 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS1224971025 |
RIGI
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1224979359 |
TANGO2
|
Health Risk |
Pathogenic |
— |
| RS1224983278 |
MCM3AP
|
Health Risk |
Likely pathogenic |
— |